Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Deals

BARDA enlisting start-ups in fight against COVID-19 via JLABS collaboration

JLABS funneling start-up innovation to BARDA via Blue Knight initiative

August 28, 2020 11:25 PM UTC

A collaboration between JLABS and BARDA gives the government agency access to start-ups that it needs to fast track new, innovative COVID-19 therapies and diagnostics it otherwise would struggle to find.

The Johnson & Johnson (NYSE:JNJ) incubator and the Biomedical Advanced Research and Development Authority (BARDA) launched the Blue Knight collaboration in April of 2019 to accelerate development of technologies that can address public health threats, including emerging infectious diseases...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article